IGFBP3

insulin like growth factor binding protein 3

93

5.56E−04

0.473

0.454

0.155

TNFSF11

tumor necrosis factor superfamily member 11

110

7.21E−04

0.482

0.474

0.153

DDIT3

DNA damage inducible transcript 3

72

4.52E−04

0.479

0.500

0.160

VTN

Vitronectin

57

4.90E−04

0.458

0.503

0.162

MET

MET proto-oncogene, receptor tyrosine kinase

79

3.31E−03

0.478

0.537

0.163

MYD88

myeloid differentiation primary response 88

102

1.22E−03

0.483

0.528

0.147

RAF1

Raf-1 proto-oncogene, serine/threonine kinase

84

5.64E−04

0.482

0.443

0.150

PLAU

plasminogen activator, urokinase

76

7.48E−04

0.475

0.477

0.160

AHR

aryl hydrocarbon receptor

80

9.65E−04

0.476

0.429

0.154

TNFRSF1A

TNF receptor superfamily member 1A

111

1.25E−03

0.488

0.496

0.148

BIRC3

baculoviral IAP repeat containing 3

64

2.09E−03

0.458

0.511

0.159

BIRC2

baculoviral IAP repeat containing 2

65

7.52E−04

0.462

0.446

0.147

XBP1

X-box binding protein 1

68

1.42E−03

0.472

0.475

0.158

ERBB3

erb-b2 receptor tyrosine kinase 3

58

4.37E−04

0.466

0.604

0.182

BIRC5

baculoviral IAP repeat containing 5

49

5.75E−04

0.445

0.514

0.154

CTSB

cathepsin B

69

5.43E−04

0.466

0.503

0.166

EPHA2

EPH receptor A2

47

4.29E−04

0.460

0.537

0.173

MAP3K5

mitogen-activated protein kinase kinasekinase 5

70

4.76E−04

0.473

0.492

0.158

ATF6

activating transcription factor 6

51

4.21E−04

0.461

0.511

0.165

MAPK9

mitogen-activated protein kinase 9

90

6.02E−04

0.484

0.498

0.159

TNFAIP3

TNF alpha induced protein 3

57

1.35E−03

0.446

0.486

0.146

TGFBR2

transforming growth factor beta receptor 2

52

4.78E−04

0.466

0.470

0.156